Natixis Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$342M Buy
2,236,156
+1,397,774
+167% +$214M 0.48% 30
2025
Q4
$116M Sell
838,382
-61,636
-7% -$8.07M 0.16% 136
2025
Q3
$115M Buy
900,018
+39,020
+5% +$4.76M 0.17% 129
2025
Q2
$104M Sell
860,998
-10,972
-1% -$1.24M 0.17% 140
2025
Q1
$97.2M Sell
871,970
-495
-0.1% -$52.7K 0.18% 129
2024
Q4
$84.9M Sell
872,465
-66,379
-7% -$7.08M 0.16% 136
2024
Q3
$108M Buy
938,844
+26,317
+3% +$2.99M 0.21% 106
2024
Q2
$97.1M Sell
912,527
-14,128
-2% -$1.42M 0.21% 104
2024
Q1
$89.6M Sell
926,655
-4,472
-0.5% -$459K 0.21% 109
2023
Q4
$94M Buy
931,127
+3,270
+0.4% +$316K 0.25% 98
2023
Q3
$94.5M Sell
927,857
-2,553
-0.3% -$259K 0.29% 78
2023
Q2
$93.9M Buy
930,410
+32,258
+4% +$3.23M 0.29% 84
2023
Q1
$82.6M Sell
898,152
-353,451
-28% -$30.9M 0.28% 90
2022
Q4
$114M Sell
1,251,603
-130,143
-9% -$11M 0.43% 53
2022
Q3
$105M Sell
1,381,746
-41,834
-3% -$3.47M 0.44% 45
2022
Q2
$120M Sell
1,423,580
-317,146
-18% -$27.8M 0.53% 27
2022
Q1
$153M Buy
1,740,726
+50,023
+3% +$4.33M 0.58% 24
2021
Q4
$148M Sell
1,690,703
-414,039
-20% -$34.4M 0.56% 29
2021
Q3
$172M Buy
2,104,742
+733,859
+54% +$66M 0.71% 18
2021
Q2
$125M Sell
1,370,883
-32,675
-2% -$2.91M 0.58% 29
2021
Q1
$120M Buy
1,403,558
+101,620
+8% +$9.12M 0.63% 26
2020
Q4
$123M Buy
1,301,938
+215,686
+20% +$18.8M 0.71% 19
2020
Q3
$94.5M Sell
1,086,252
-76,502
-7% -$6.63M 0.59% 28
2020
Q2
$102M Sell
1,162,754
-51,554
-4% -$4.45M 0.67% 24
2020
Q1
$100M Buy
1,214,308
+104,856
+9% +$9.36M 0.82% 19
2019
Q4
$105M Buy
1,109,452
+82,276
+8% +$7.38M 0.74% 20
2019
Q3
$89.3M Sell
1,027,176
-38,867
-4% -$3.49M 0.71% 22
2019
Q2
$97.3M Sell
1,066,043
-93,939
-8% -$7.95M 0.8% 16
2019
Q1
$89.5M Buy
1,159,982
+32,506
+3% +$2.61M 0.78% 15
2018
Q4
$86.7M Buy
1,127,476
+134,221
+14% +$10.4M 0.86% 18
2018
Q3
$76.7M Buy
993,255
+79,338
+9% +$5.87M 0.68% 23
2018
Q2
$61.9M Sell
913,917
-44,807
-5% -$3.09M 0.59% 25
2018
Q1
$69.5M Buy
958,724
+18,493
+2% +$1.41M 0.69% 24
2017
Q4
$70.7M Sell
940,231
-57,509
-6% -$4.34M 0.72% 24
2017
Q3
$76.8M Sell
997,740
-148,164
-13% -$11.2M 0.81% 20
2017
Q2
$85.7M Sell
1,145,904
-23,215
-2% -$1.65M 0.93% 14
2017
Q1
$77.8M Buy
1,169,119
+108,304
+10% +$7.22M 0.86% 15
2016
Q4
$69.2M Sell
1,060,815
-66,059
-6% -$4.29M 0.83% 15
2016
Q3
$79.7M Buy
1,126,874
+52,006
+5% +$3.79M 1.03% 10
2016
Q2
$79.5M Buy
1,074,868
+208,228
+24% +$14.4M 1.1% 6
2016
Q1
$56.3M Buy
866,640
+224,224
+35% +$15.3M 0.84% 15
2015
Q4
$49.5M Buy
642,416
+18,153
+3% +$1.44M 0.81% 15
2015
Q3
$51.4M Buy
624,263
+40,842
+7% +$3.63M 0.89% 12
2015
Q2
$51.4M Buy
583,421
+46,600
+9% +$4.28M 0.87% 9
2015
Q1
$47.4M Buy
536,821
+52,766
+11% +$4.68M 0.83% 8
2014
Q4
$40.2M Buy
484,055
+75,870
+19% +$6.29M 0.75% 8
2014
Q3
$34.4M Sell
408,185
-127,513
-24% -$10.3M 0.69% 10
2014
Q2
$43.5M Buy
535,698
+17,859
+3% +$1.4M 0.62% 12
2014
Q1
$39.5M Sell
517,839
-33,041
-6% -$2.41M 0.61% 10
2013
Q4
$39.7M Sell
550,880
-33,901
-6% -$2.36M 0.65% 11
2013
Q3
$40.2M Buy
584,781
+47,600
+9% +$3.15M 0.74% 7
2013
Q2
$34M Buy
+537,181
New +$35M 0.68% 9

Other funds holding NVS

Natixis Advisors's NVS Position: Q1 2026 in Review

Natixis Advisors increased its Novartis (NVS) stake by 167% in Q1 2026, buying an estimated $214M and bringing the position to 2,236,156 shares worth $342M. The position accounts for 0.48% of the portfolio, ranked #30.

Natixis Advisors first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Natixis Advisors held 2,236,156 shares of Novartis worth $342M as of Q1 2026.
  • Natixis Advisors bought 1,397,774 Novartis shares in Q1 2026, an estimated $214M.
  • Novartis made up 0.48% of Natixis Advisors's portfolio in Q1 2026, its #30 holding.
  • Natixis Advisors first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.